WARD-Home - Continuous Monitoring of Vital Parameters After Discharge

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

June 15, 2022

Study Completion Date

June 15, 2022

Conditions
Vital SignClinical Deterioration
Interventions
DEVICE

Continuously monitoring

Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discharge. Monitoring will last for a maximum of eight days.

Trial Locations (1)

2400

Bispebjerg and Frederiksberg hospital, København NV

All Listed Sponsors
collaborator

Technical University of Denmark

OTHER

collaborator

University Hospital Bispebjerg and Frederiksberg

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT05223504 - WARD-Home - Continuous Monitoring of Vital Parameters After Discharge | Biotech Hunter | Biotech Hunter